121 related articles for article (PubMed ID: 9638537)
1. Flow cytometric assays to detect platelet activation and aggregation in device-implanted calves.
Baker LC; Davis WC; Autieri J; Watach MJ; Yamazaki K; Litwak P; Wagner WR
J Biomed Mater Res; 1998 Aug; 41(2):312-21. PubMed ID: 9638537
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices.
Snyder TA; Watach MJ; Litwak KN; Wagner WR
Ann Thorac Surg; 2002 Jun; 73(6):1933-8. PubMed ID: 12078793
[TBL] [Abstract][Full Text] [Related]
3. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation.
Snyder TA; Tsukui H; Kihara S; Akimoto T; Litwak KN; Kameneva MV; Yamazaki K; Wagner WR
J Biomed Mater Res A; 2007 Apr; 81(1):85-92. PubMed ID: 17109415
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric assays for quantifying activated ovine platelets.
Johnson CA; Snyder TA; Woolley JR; Wagner WR
Artif Organs; 2008 Feb; 32(2):136-45. PubMed ID: 18005275
[TBL] [Abstract][Full Text] [Related]
5. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry.
Shattil SJ; Cunningham M; Hoxie JA
Blood; 1987 Jul; 70(1):307-15. PubMed ID: 3297204
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry.
Fox SC; Sasae R; Janson S; May JA; Heptinstall S
Platelets; 2004 Mar; 15(2):85-93. PubMed ID: 15154600
[TBL] [Abstract][Full Text] [Related]
7. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
Nkambule BB; Davison G; Ipp H
Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
[TBL] [Abstract][Full Text] [Related]
8. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation.
Tarnow I; Kristensen AT; Krogh AK; Frelinger AL; Barnard MR; Michelson AD
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):345-52. PubMed ID: 18405981
[TBL] [Abstract][Full Text] [Related]
9. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of blood pump induced platelet microaggregates between a centrifugal and roller pump during cardiopulmonary bypass.
Linneweber J; Chow TW; Kawamura M; Moake JL; Nosè Y
Int J Artif Organs; 2002 Jun; 25(6):549-55. PubMed ID: 12117295
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet aggregation by an SLE-derived human hybridoma autoantibody against an activation-dependent antigen.
Xu H; Frojmovic MM; Wong T; Rauch J
Thromb Haemost; 1995 Oct; 74(4):1152-62. PubMed ID: 8560428
[TBL] [Abstract][Full Text] [Related]
13. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations.
Frojmovic M; Wong T
Biophys J; 1991 Apr; 59(4):828-37. PubMed ID: 1905967
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte-platelet aggregates and monocyte tissue factor expression in bovines implanted with ventricular assist devices.
Snyder TA; Litwak KN; Tsukui H; Akimoto T; Kihara S; Yamazaki K; Wagner WR
Artif Organs; 2007 Feb; 31(2):126-31. PubMed ID: 17298401
[TBL] [Abstract][Full Text] [Related]
15. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
Matzdorff A; Voss R
Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
[TBL] [Abstract][Full Text] [Related]
17. Measurement of platelet activation by fluorescence-activated flow cytometry.
Corash L
Blood Cells; 1990; 16(1):97-106; discussion 107-8. PubMed ID: 1693536
[TBL] [Abstract][Full Text] [Related]
18. Detection of activated platelets and platelet-leukocyte aggregates in horses.
Weiss DJ; Evanson OA
Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation studies with anti-CD41/61 monoclonal antibodies.
Mateo A; Perez de la Lastra JM; Garrido JJ; Llanes D
Vet Immunol Immunopathol; 1996 Aug; 52(4):357-62. PubMed ID: 8896225
[TBL] [Abstract][Full Text] [Related]
20. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
Chronos NA; Wilson DJ; Janes SL; Hutton RA; Buller NP; Goodall AH
Clin Sci (Lond); 1994 Nov; 87(5):575-80. PubMed ID: 7533066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
